Jiangsu Yuyue Medical Equipment & Supply and Sunny Optical Technology Group have postponed their investments in Ant Group’s consumer finance unit after state-sponsored Cinda was required to halt its participation.

The corporate's ongoing Latin American portfolio has grown after it led pet product retailer Laika's $48m series B round and a $40m round for rural finance provider TerraMagna.

SoftBank led 5G chip developer Eigencomm's $157m series C round while smart bank Seba Bank raised $120m in its own series C, which included Alameda Research.

Tencent led a nine-figure round valuing the hospitality software provider at $1.25bn as the industry’s digitalisation gathers pace.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.

Manulife and Shell helped the solar power provider raise the cash as Exelon-backed residential solar energy supplier PosiGen secured $100m, showing continuing interest in the solar power space.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

As animal-free dairy alternatives become more popular, Hochland and Tnuva both took part in the vegan dairy technology developer's latest round.